2 results
Approved WMOCompleted
Evaluate the long-term safety and effectiveness of two dose levels of orally administered BCX7353 in subjects with HAE
Approved WMORecruiting
The aim of this prospective single-arm phase II study is to evaluate the efficacy of amivantamab and bevacizumab added to continued treatment with a third-generation EGFRTKI (osimertinib or lazertinib), for patients with EGFR-mutant advanced NSCLC,…